Just in case you are new to biotech, the Holy Grail is usually FDA approval to be able to sell in the US.
FDA approval requires three trials sequentially (sometimes reduceable to two trials if FDA grants the exemption).
Phase 1 trial tests that the drug does not harm healthy individuals.
Phase 2 trial tests that the drug provides some benefit.
Phase 3 trial is a further test if Phase 2 has positive outcome.
After these trials (which can take several years each) you apply for FDA approval which can take another 6 months.
After approval you start your marketing campaign which takes a few months.
Then you sell and get revenue.
- Forums
- ASX - By Stock
- Novatti banking license application .IBOA
Just in case you are new to biotech, the Holy Grail is usually...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
Add NOV (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
0.002(3.77%) |
Mkt cap ! $19.56M |
Open | High | Low | Value | Volume |
5.5¢ | 5.5¢ | 5.5¢ | $0 | 4 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 33416 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.051 |
4 | 65000 | 0.050 |
1 | 131137 | 0.049 |
2 | 299167 | 0.048 |
2 | 32000 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 33416 | 3 |
0.060 | 5000 | 1 |
0.063 | 27000 | 1 |
0.064 | 10000 | 1 |
0.068 | 21741 | 1 |
Last trade - 10.06am 02/08/2024 (20 minute delay) ? |
Featured News
NOV (ASX) Chart |